PIPR — Piper Sandler Companies Share News
0.000.00%
- $5.41bn
- $5.34bn
- $1.90bn
U.S. RESEARCH ROUNDUP- Equifax, Johnson & Johnson, Morgan Stanley
Esperion Therapeutics tumbles on $75 mln equity raise
Brief: Piper Sandler Expands Technology Investment Banking Team With The Additions Of Eric Matthews And Keith Schellhorn
Galaxy Digital up after Piper Sandler raises PT on growth optimism
US FDA approves Crinetics' oral pill for rare hormone disorder (updated)
US FDA approves Crinetics' oral pill for rare hormone disorder
Brief: Piper Sandler Completes Acquisition Of G Squared Capital Partners
U.S. RESEARCH ROUNDUP- IQVIA Holdings, Reliance, United Therapeutics
Investment banks climb after Powell stokes rate cut hopes
Piper Sandler Companies reports results for the quarter ended June 30 - Earnings Summary
Brief: Piper Sandler Companies Reports Second Quarter 2025 Results
Brief: Piper Sandler Q2 EPS USD 2.38
Piper Sandler reduces Lululemon's PT on innovation spending concerns
Inovio Pharma plunges on $25 mln stock-and-warrants offering
Inovio Pharma dives on equity offering plans
Two investment banks seek freedom from US SEC analyst research settlement (updated)
Two investment banks seek freedom from US SEC analyst research settlement
Brief: Piper Sandler Strengthens Insurance Investment Banking Team with the Addition of Alex Ring
U.S. RESEARCH ROUNDUP- Intuitive Surgical, Oracle, Regeneron Pharmaceuticals